330 related articles for article (PubMed ID: 11521175)
1. Pathology and pathogenesis of intrahepatic bile duct loss.
Nakanuma Y; Tsuneyama K; Harada K
J Hepatobiliary Pancreat Surg; 2001; 8(4):303-15. PubMed ID: 11521175
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of the intrahepatic biliary epithelium.
Glaser S; Francis H; Demorrow S; Lesage G; Fava G; Marzioni M; Venter J; Alpini G
World J Gastroenterol; 2006 Jun; 12(22):3523-36. PubMed ID: 16773709
[TBL] [Abstract][Full Text] [Related]
3. Florid duct lesions and extensive bile duct loss of the intrahepatic biliary tree in chronic liver diseases other than primary biliary cirrhosis.
Nakanuma Y; Ohta G; Takeshita H; Yamazaki Y; Doishita K; Shimizu M
Acta Pathol Jpn; 1983 Nov; 33(6):1095-104. PubMed ID: 6670548
[TBL] [Abstract][Full Text] [Related]
4. The intrahepatic cholangiopathies.
Birnbaum A; Suchy FJ
Semin Liver Dis; 1998; 18(3):263-9. PubMed ID: 9773426
[TBL] [Abstract][Full Text] [Related]
5. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic bile duct loss in immune-mediated ductopenic biliary diseases with an emphasis on biliary epithelial apoptosis.
Harada K; Nakanuma Y
Minerva Gastroenterol Dietol; 2003 Mar; 49(1):41-51. PubMed ID: 16481970
[TBL] [Abstract][Full Text] [Related]
7. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree.
Harada K; Ohba K; Ozaki S; Isse K; Hirayama T; Wada A; Nakanuma Y
Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of the intrahepatic biliary epithelium.
Strazzabosco M; Spirlí C; Okolicsanyi L
J Gastroenterol Hepatol; 2000 Mar; 15(3):244-53. PubMed ID: 10764023
[TBL] [Abstract][Full Text] [Related]
9. Destructive intrahepatic bile duct diseases.
Desmet VJ
Recenti Prog Med; 1990 Jun; 81(6):392-8. PubMed ID: 2251446
[TBL] [Abstract][Full Text] [Related]
10. Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss.
Sasaki M; Ikeda H; Haga H; Manabe T; Nakanuma Y
J Pathol; 2005 Mar; 205(4):451-9. PubMed ID: 15685690
[TBL] [Abstract][Full Text] [Related]
11. Hepatic sarcoidosis with vanishing bile duct syndrome, cirrhosis, and portal phlebosclerosis. Report of an autopsy case.
Nakanuma Y; Kouda W; Harada K; Hiramatsu K
J Clin Gastroenterol; 2001 Feb; 32(2):181-4. PubMed ID: 11205661
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of cholangiopathies.
Strazzabosco M; Fabris L; Spirli C
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S90-S102. PubMed ID: 15758666
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic bile duct loss in primary sclerosing cholangitis: a quantitative study.
Casali AM; Carbone G; Cavalli G
Histopathology; 1998 May; 32(5):449-53. PubMed ID: 9639121
[TBL] [Abstract][Full Text] [Related]
14. A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors.
Oguma S; Belle S; Starzl TE; Demetris AJ
Hepatology; 1989 Feb; 9(2):204-9. PubMed ID: 2643544
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
Pusl T; Beuers U
World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
[TBL] [Abstract][Full Text] [Related]
17. Restoration of bile ducts in drug-induced vanishing bile duct syndrome due to zonisamide.
Vuppalanchi R; Chalasani N; Saxena R
Am J Surg Pathol; 2006 Dec; 30(12):1619-23. PubMed ID: 17122520
[TBL] [Abstract][Full Text] [Related]
18. New monoclonal antibodies reacting with bile ducts: further insights into the pathogenesis of bile ductular proliferation in biliary diseases.
Ayres RC; Hübscher SG; Shaw J; Garner C; Joplin R; Williams A; Neuberger JM
J Pathol; 1991 Oct; 165(2):153-61. PubMed ID: 1720818
[TBL] [Abstract][Full Text] [Related]
19. The syndrome of disappearing intrahepatic bile ducts.
Sherlock S
Lancet; 1987 Aug; 2(8557):493-6. PubMed ID: 2887786
[TBL] [Abstract][Full Text] [Related]
20. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
